Author

Pei San Yee

Observed name: P.S. Yee

Institution: Cancer Research Malaysia

Observed institutions: University of Malaya, Cancer Research Malaysia, Subang Jaya Medical Centre

ORCID: 0000-0002-6548-2149

Observed ORCID: 0000-0002-6548-2149

OpenAlex ID: A5019937163

Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies

2016 · Muhammad Zaki Hidayatullah Fadlullah, Ivy Kim-Ni Chiang, et al. · Oncotarget · 67

Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway

2020 · Annie Wai Yeeng Chai, Pei San Yee, et al. · eLife · 56

Common Oncogenic Mutations Are Infrequent in Oral Squamous Cell Carcinoma of Asian Origin

2013 · Sharifah Nurain Syed Zanaruddin, Pei San Yee, et al. · PLoS ONE · 48

PDF

Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells

2017 · Nur Syafinaz Zainal, Chai Phei Gan, et al. · Phytomedicine · 44

IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells

2019 · Chai Phei Gan, Kin Kit Sam, et al. · Cellular Oncology · 37

Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models

2019 · Pei San Yee, Nur Syafinaz Zainal, et al. · Targeted Oncology · 19

Establishment and Characterization of an Epstein-Barr Virus–positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma

2024 · Annie Wai Yeeng Chai, Shi Mun Yee, et al. · Cancer Research Communications · 13

PDF

Novel MDM2 splice variants identified from oral squamous cell carcinoma

2012 · Kin Kit Sam, Chai Phei Gan, et al. · Oral Oncology · 12

Rational Combinations of Targeted Therapy and Immune Checkpoint Inhibitors in Head and Neck Cancers

2022 · Annie Wai Yeeng Chai, Pei San Yee, et al. · Frontiers in Oncology · 8

TNO155 is a selective SHP2 inhibitor to target PTPN11-dependent oral squamous cell carcinoma

2024 · Annie Wai Yeeng Chai, Yee Hua Tan, et al. · Heliyon · 7

The 4717C > G polymorphism in periplakin modulates sensitivity to EGFR inhibitors

2019 · Hui Mei Lee, Gregory Michael Kelly, et al. · Scientific Reports · 6

PDF

Interferon‐Inducible ADAR1 p150 Is Essential for the Survival of Oral Squamous Cell Carcinoma

2025 · Pei San Yee, Annie Wai Yeeng Chai, et al. · Molecular Carcinogenesis · 4

QuickCount ® : a Novel Automated Software for Rapid Cell Detection and Quantification

2018 · Kai Hung Tiong, Jit Kang Chang, et al. · BioTechniques · 4

PDF

High TNF and NF-κB Pathway Dependency Are Associated with AZD5582 Sensitivity in OSCC via CASP8-Dependent Apoptosis

2024 · Annie Wai Yeeng Chai, Yee Hua Tan, et al. · Cancer Research Communications · 2

Supplementary Figure 2 from Establishment and Characterization of an Epstein-Barr Virus–positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma

2024 · Annie Wai Yeeng Chai, Shi Mun Yee, et al. · 1

Abstract 1226: Targeting OSCC fitness genes YAP1 and WWTR1 via synergistic killing of CA3 in combination with cisplatin

2021 · Annie Wai Yeeng Chai, Pei San Yee, et al. · Cancer Research · 1

Resistance to dasatinib is associated with the activation of Akt in oral squamous cell carcinoma

2017 · Pei San Yee, Chai Phei Gan, et al. · Translational Research in Oral Oncology · 1

PDF

The Zα domain of ADAR1: emerging roles in cancer biology and evidence as a promising therapeutic target

2026 · Jie Ying Teo, Pei San Yee, et al. · Cancer Biology & Therapy

PDF

Abstract 504: Interferon enriched gene expression signatures are associated with ADAR1 dependency in oral squamous cell carcinoma.

2026 · Pei San Yee, Jie Ying Teo, et al. · Cancer Research

Abstract 2414: Targeting the interferon-inducible isoform, p150 of ADAR1 for the treatment of oral squamous cell carcinoma (OSCC)

2026 · Annie Wai Yeeng Chai, Pei San Yee, et al. · Cancer Research

Supplementary Figure 6 from High TNF and NF-κB Pathway Dependency Are Associated with AZD5582 Sensitivity in OSCC via CASP8-Dependent Apoptosis